CRISPR, Gene Editing & DNA-Repair Antibodies
CRISPR efficiency is only part of the result. Evaluate DNA-damage signaling, repair-pathway activation, and editing outcomes with antibodies targeting Cas9, RAD51, BRCA2, DNA-PK, γH2AX, ATM, ATR, and other key genome-stability proteins.
Catalog #1: bs-1370R-Cy5.5
Applications: WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity: Human
Conjugate: Cy5.5
Catalog #1: bs-1370R-FITC
Applications: WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity: Human
Conjugate: FITC
Catalog #1: bs-1370R-Cy7
Applications: WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity: Human
Conjugate: Cy7
Catalog #1: bs-1370R-Cy5
Applications: WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity: Human
Conjugate: Cy5
Catalog #1: bs-1370R-Cy3
Applications: WB, FCM, IF(IHC-P), IF(IHC-F), IF(ICC)
Reactivity: Human
Conjugate: Cy3